Wu-Ming Qin

716 citations
13 papers · 571 indexed · 1 hit paper · h-index 9
Topics
Cancer Mechanisms and Therapy (2 papers)Drug Transport and Resistance Mechanisms (2 papers)Sexual function and dysfunction studies (2 papers)
Partner nations
ChinaSpainMacao

In The Last Decade

Wu-Ming Qin

12 papers receiving 567 citations

Hit Papers

Role of PI3K/Akt signaling pathway in cardiac fibrosis2021202620222024202150100150

Peers

Wu-Ming Qin
Comparison fields: 5 of 82
  • Molecular Biology 340
  • Oncology 159
  • Pulmonary and Respiratory Medicine 77
  • Cancer Research 69
  • Cardiology and Cardiovascular Medicine 67
Replace Siyu Guo with:
Siyu Guo China
Weiwei Shao China
Yunpeng Xie China
Ae Jin Jeong South Korea
Jong Sil Lee South Korea
Guowang Yang China
Sławomir Mańdziuk Poland
Wu-Ming Qin relative to Siyu Guo China Siyu Guo's profile →
Citations per field
00.5×11.3×
Siyu Guo · 1×
Citations per year

Countries citing papers authored by Wu-Ming Qin

Since Specialization
Citations

This map shows the geographic impact of Wu-Ming Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu-Ming Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu-Ming Qin more than expected).

Fields of papers citing papers by Wu-Ming Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu-Ming Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu-Ming Qin. The network helps show where Wu-Ming Qin may publish in the future.

Co-authorship network of co-authors of Wu-Ming Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Wu-Ming Qin. A scholar is included among the top collaborators of Wu-Ming Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu-Ming Qin. Wu-Ming Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 2
3
Role of PI3K/Akt signaling pathway in cardiac fibrosisbreakdown →
177
4 1
5
Cyclin-dependent kinase 7 inhibitor THZ2 inhibits the growth of human gastric cancer in vitro and in vivo.
26
6 31
7
Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
12
8 61
9 56
10 1
11 53
12
Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo.
78
13 73

About Wu-Ming Qin

Wu-Ming Qin is a scholar working on Oncology, Biochemistry and Biochemistry, having authored 13 papers that have together received 571 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Sexual function and dysfunction studies (2 papers). The work is most often cited by research in Pharmacology (57 citations), Oncology (159 citations) and Complementary and alternative medicine (44 citations). Wu-Ming Qin has collaborated with scholars based in China, Spain and Macao. Frequent co-authors include Linghui Cao, Isaac Yaw Massey, Zhi Shi, Qiwei Jiang, Xiao-Long Mei, Youqiu Xue, Jian-Ge Qiu, Wenji Zhang, Meng-Ning Wei and Di-Wei Zheng. Their work appears in journals such as Cancer Letters, Oncotarget and Oxidative Medicine and Cellular Longevity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026